SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
His most recent stint was with Danone India as its Managing Director
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
Subscribe To Our Newsletter & Stay Updated
